Provision of no-cost contraception and promotion of the most effective contraceptive methods result in greatly reduced rates of abortions, repeat abortions, and teenage birth rates, according to a recent study.
FDA grants 510(k) clearance to chemiluminescence-based immunoassay
Published: January 10th 2025 | Updated: January 10th 2025The automated chemiluminescence-based immunoassay has received clearance for free testosterone, providing enhanced diagnostic options to a multitude of conditions.
Read More